Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling
暂无分享,去创建一个
M. Monshouwer | L. D. De Zwart | J. Snoeys | J. de Jong | J. Sukbuntherng | E. Mannaert | L. Zwart | J. Jong